These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 33692858)

  • 1. Four potential microRNAs affect the progression of pancreatic ductal adenocarcinoma by targeting MET via the PI3K/AKT signaling pathway.
    Yao LC; Jiang XH; Yan SS; Wang W; Wu L; Zhai LL; Xiang F; Ji T; Ye L; Tang ZG
    Oncol Lett; 2021 Apr; 21(4):326. PubMed ID: 33692858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying
    Ding J; Liu Y; Lai Y
    PeerJ; 2020; 8():e10419. PubMed ID: 33282565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
    Shang M; Zhang L; Chen X; Zheng S
    Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of potential hub genes associated with the pathogenesis and prognosis of pancreatic duct adenocarcinoma using bioinformatics meta-analysis of multi-platform datasets.
    Ma Y; Pu Y; Peng L; Luo X; Xu J; Peng Y; Tang X
    Oncol Lett; 2019 Dec; 18(6):6741-6751. PubMed ID: 31807183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.
    Zhou J; Hui X; Mao Y; Fan L
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of ASPM, BUB1B and SPDL1 in tumor tissues predicts poor survival in patients with pancreatic ductal adenocarcinoma.
    Tian X; Wang N
    Oncol Lett; 2020 Apr; 19(4):3307-3315. PubMed ID: 32218868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of key regulators of pancreatic ductal adenocarcinoma using bioinformatics analysis of microarray data.
    Li N; Zhao X; You S
    Medicine (Baltimore); 2019 Jan; 98(2):e14074. PubMed ID: 30633213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of differentially expressed genes in pancreatic ductal adenocarcinoma and normal pancreatic tissues based on microarray datasets.
    Liu L; Wang S; Cen C; Peng S; Chen Y; Li X; Diao N; Li Q; Ma L; Han P
    Mol Med Rep; 2019 Aug; 20(2):1901-1914. PubMed ID: 31257501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of key pathways and candidate genes in pancreatic ductal adenocarcinoma using bioinformatics analysis.
    He Y; Liu Y; Gong J; Liu C; Zhang H; Wu H
    Oncol Lett; 2019 Apr; 17(4):3751-3764. PubMed ID: 30881497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Key Prognostic Biomarker and Its Correlation with Immune Infiltrates in Pancreatic Ductal Adenocarcinoma.
    Luan H; Zhang C; Zhang T; He Y; Su Y; Zhou L
    Dis Markers; 2020; 2020():8825997. PubMed ID: 32934754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated transcriptome meta-analysis of pancreatic ductal adenocarcinoma and matched adjacent pancreatic tissues.
    Atay S
    PeerJ; 2020; 8():e10141. PubMed ID: 33194391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Hub Genes in Pancreatic Ductal Adenocarcinoma Using Bioinformatics Analysis.
    Wang C; Guo J; Zhao X; Jia J; Xu W; Wan P; Sun C
    Iran J Public Health; 2021 Nov; 50(11):2238-2245. PubMed ID: 35223598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
    Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
    Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatic Analysis Suggests That Three Hub Genes May Be a Vital Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma.
    Chang X; Yang MF; Fan W; Wang LS; Yao J; Li ZS; Li DF
    J Comput Biol; 2020 Nov; 27(11):1595-1609. PubMed ID: 32216644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated bioinformatics analysis of potential biomarkers for pancreatic cancer.
    Shi H; Xu H; Chai C; Qin Z; Zhou W
    J Clin Lab Anal; 2022 May; 36(5):e24381. PubMed ID: 35403252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of key microRNAs and their targets in exosomes of pancreatic cancer using bioinformatics analysis.
    Zhao X; Ren Y; Cui N; Wang X; Cui Y
    Medicine (Baltimore); 2018 Sep; 97(39):e12632. PubMed ID: 30278585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of potential target genes in pancreatic ductal adenocarcinoma by bioinformatics analysis.
    Tang Y; Zhang Z; Tang Y; Chen X; Zhou J
    Oncol Lett; 2018 Aug; 16(2):2453-2461. PubMed ID: 30013637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of abnormal expression, prognostic value and oncogenic role of the hub gene FN1 in pancreatic ductal adenocarcinoma
    Lei X; Chen G; Li J; Wen W; Gong J; Fu J
    PeerJ; 2021; 9():e12141. PubMed ID: 34567847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Necroptosis-Related Prognostic Model for Pancreatic Carcinoma Reveals Its Invasion and Metastasis Potential through Hybrid EMT and Immune Escape.
    Liu H; Li Z; Zhang L; Zhang M; Liu S; Wang J; Yang C; Peng Q; Du C; Jiang N
    Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of potential pain genes in pancreatic ductal adenocarcinoma (PDAC) based on bioinformatics methods.
    Xu Q; Wang W; Hu H; Ji S
    J Gastrointest Oncol; 2023 Feb; 14(1):420-428. PubMed ID: 36915423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.